Correlation between serum caffeine levels and changes in cytokine profile in a cohort of preterm infants

Journal of Pediatrics

Volumn 158, Issue 1, 2011, Pages 57-64.e1

  Chavez Valdez, Raul ^a,b   Ahlawat, Rajni ^a   Wills Karp, Marsha ^c   Nathan, Amy ^c   Ezell, Tarrah ^d   Gauda, Estelle B ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b TEXAS TECH UNIVERSITY   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

^d MORGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMAN; LUNG DYSPLASIA; MALE; NEWBORN; NEWBORN APNEA; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; TRACHEAL ASPIRATION PROCEDURE;

EID: 78649985801     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2010.06.051     Document Type: Article

References (54)

1. B. Schmidt, R.S. Roberts, P. Davis, L.W. Doyle, K.J. Barrington, and A. Ohlsson Caffeine therapy for apnea of prematurity N Engl J Med 354 2006 2112 2121
2. B. Schmidt, R.S. Roberts, P. Davis, L.W. Doyle, K.J. Barrington, and A. Ohlsson Long-term effects of caffeine therapy for apnea of prematurity N Engl J Med 357 2007 1893 1902
3. E. Herlenius, U. Aden, L.Q. Tang, and H. Lagercrantz Perinatal respiratory control and its modulation by adenosine and caffeine in the rat Pediatr Res 51 2002 4 12
4. J.M. Lopes, G.M. Davis, K. Mullahoo, and J.V. Aranda Role of adenosine in the hypoxic ventilatory response of the newborn piglet Pediatr Pulmonol 17 1994 50 55
5. D. Millar, and B. Schmidt Controversies surrounding xanthine therapy Semin Neonatol 9 2004 239 244
6. R. Chavez-Valdez, M. Wills-Karp, R. Ahlawat, E.A. Cristofalo, A. Nathan, and E.B. Gauda Caffeine modulates TNF-alpha production by cord blood monocytes: the role of adenosine receptors Pediatr Res 65 2009 203 208
7. L.A. Horrigan, J.P. Kelly, and T.J. Connor Caffeine suppresses TNF-alpha production via activation of the cyclic AMP/protein kinase A pathway Int Immunopharmacol 4 2004 1409 1417
8. M.C. Montesinos, J.S. Yap, A. Desai, I. Posadas, C.T. McCrary, and B.N. Cronstein Reversal of the antiinflammatory effects of methotrexate by the nonselective adenosine receptor antagonists theophylline and caffeine: evidence that the antiinflammatory effects of methotrexate are mediated via multiple adenosine receptors in rat adjuvant arthritis Arthritis Rheum 43 2000 656 663
9. A. Ohta, D. Lukashev, E.K. Jackson, B.B. Fredholm, and M. Sitkovsky 1,3,7-trimethylxanthine (caffeine) may exacerbate acute inflammatory liver injury by weakening the physiological immunosuppressive mechanism J Immunol 179 2007 7431 7438
10. S.P. Tofovic, E.M. Salah, E.K. Jackson, and M. Melhem Early renal injury induced by caffeine consumption in obese, diabetic ZSF1 rats Ren Fail 29 2007 891 902
11. A.M. Comer, C.M. Perry, and D.P. Figgitt Caffeine citrate: a review of its use in apnoea of prematurity Paediatr Drugs 3 2001 61 79
12. H. Harrison Jr. Apnea of prematurity: theophylline v caffeine Alaska Med 34 1992 173 176
13. G. Natarajan, M.L. Botica, R. Thomas, and J.V. Aranda Therapeutic drug monitoring for caffeine in preterm neonates: an unnecessary exercise? Pediatrics 119 2007 936 940
14. G. Ginsberg, D. Hattis, and B. Sonawane Incorporating pharmacokinetic differences between children and adults in assessing children's risks to environmental toxicants Toxicol Appl Pharmacol 198 2004 164 183
15. J.C. Le Guennec, B. Billon, and C. Pare Maturational changes of caffeine concentrations and disposition in infancy during maintenance therapy for apnea of prematurity: influence of gestational age, hepatic disease, and breast-feeding Pediatrics 76 1985 834 840
16. I. Gillot, J.B. Gouyon, and J.P. Guignard Renal effects of caffeine in preterm infants Biol Neonate 58 1990 133 136
17. J.V. Aranda, S. Chemtob, N. Laudignon, and B.I. Sasyniuk Pharmacologic effects of theophylline in the newborn J Allergy Clin Immunol 78 1986 773 780
18. M.M. Lahra, P.J. Beeby, and H.E. Jeffery Intrauterine inflammation, neonatal sepsis, and chronic lung disease: a 13-year hospital cohort study Pediatrics 123 2009 1314 1319
19. J.L. Ballard, J.C. Khoury, K. Wedig, L. Wang, B.L. Eilers-Walsman, and R. Lipp New Ballard score, expanded to include extremely premature infants J Pediatr 119 1991 417 423
20. J.C. Hauth, L.C. Gilstrap 3rd, G.D. Hankins, and K.D. Connor Term maternal and neonatal complications of acute chorioamnionitis Obstet Gynecol 66 1985 59 62
21. E. Mueller-Heubach, D.N. Rubinstein, and S.S. Schwarz Histologic chorioamnionitis and preterm delivery in different patient populations Obstet Gynecol 75 1990 622 626
22. F.A. Manning, I. Morrison, I.R. Lange, C.R. Harman, and P.F. Chamberlain Fetal assessment based on fetal biophysical profile scoring: experience in 12 620 referred high-risk pregnancies. I. Perinatal mortality by frequency and etiology Am J Obstet Gynecol 151 1985 343 350
23. D.K. Richardson, J.E. Gray, M.C. McCormick, K. Workman, and D.A. Goldmann Score for Neonatal Acute Physiology: a physiologic severity index for neonatal intensive care Pediatrics 91 1993 617 623
24. D.K. Richardson, C.S. Phibbs, J.E. Gray, M.C. McCormick, K. Workman-Daniels, and D.A. Goldmann Birth weight and illness severity: independent predictors of neonatal mortality Pediatrics 91 1993 969 975
25. A.T. Shennan, M.S. Dunn, A. Ohlsson, K. Lennox, and E.M. Hoskins Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period Pediatrics 82 1988 527 532
26. H.L. Wong, R.M. Pfeiffer, T.R. Fears, R. Vermeulen, S. Ji, and C.S. Rabkin Reproducibility and correlations of multiplex cytokine levels in asymptomatic persons Cancer Epidemiol Biomarkers Prev 17 2008 3450 3456
27. D.J. Henderson-Smart, and P.G. Davis Prophylactic methylxanthine for extubation in preterm infants Cochrane Database Syst Rev 2000 CD000139
28. D.J. Henderson-Smart, and P.A. Steer Prophylactic methylxanthine for preventing of apnea in preterm infants Cochrane Database Syst Rev 2000 CD000432
29. W. Du, I. Warrier, V. Tutag Lehr, V. Salari, E. Ostrea, and J.V. Aranda Changing patterns of drug utilization in a neonatal intensive care population Am J Perinatol 23 2006 279 285
30. B.G. Charles, S.R. Townsend, P.A. Steer, V.J. Flenady, P.H. Gray, and A. Shearman Caffeine citrate treatment for extremely premature infants with apnea: population pharmacokinetics, absolute bioavailability, and implications for therapeutic drug monitoring Ther Drug Monit 30 2008 709 716
31. R.B. Reiter-Reisacher, M. Wald, M. Weninger, and K.R. Herkner Caffeine monitoring in infants: comparison of automated (VITROS 5, 1 FS) chemistry system versus HPLC analysis Clin Lab 54 2008 89 94
32. A.E. Leon, K. Michienzi, C.X. Ma, and A.A. Hutchison Serum caffeine concentrations in preterm neonates Am J Perinatol 24 2007 39 47
33. A.M. van Furth, E.M. Seijmonsbergen, J.A. Langermans, P.H. van der Meide, and R. van Furth Effect of xanthine derivates and dexamethasone on Streptococcus pneumoniae-stimulated production of tumor necrosis factor alpha, interleukin-1 beta (IL-1 beta), and IL-10 by human leukocytes Clin Diagn Lab Immunol 2 1995 689 692
34. M. Ritter, K. Hohenberger, P. Alter, M. Herzum, J. Tebbe, and M. Maisch Caffeine inhibits cytokine expression in lymphocytes Cytokine 30 2005 177 181
35. L.A. Rosenthal, D.D. Taub, M.A. Moors, and K.J. Blank Methylxanthine-induced inhibition of the antigen- and superantigen-specific activation of T and B lymphocytes Immunopharmacology 24 1992 203 217
36. L.A. Horrigan, J.P. Kelly, and T.J. Connor Immunomodulatory effects of caffeine: friend or foe? Pharmacol Ther 111 2006 877 892
37. A.H. Thomson, S. Kerr, and S. Wright Population pharmacokinetics of caffeine in neonates and young infants Ther Drug Monit 18 1996 245 253
38. H. Skopnik, U. Bergt, and G. Heimann Neonatal theophylline intoxication: pharmacokinetics and clinical evaluation Eur J Pediatr 151 1992 221 224
39. S. al-Alaiyan, S. al-Rawithi, D. Raines, A. Yusuf, E. Legayada, and M.M. Shoukri Caffeine metabolism in premature infants J Clin Pharmacol 41 2001 620 627
40. L.M. Grosso, E.W. Triche, K. Belanger, N.L. Benowitz, T.R. Holford, and M.B. Bracken Caffeine metabolites in umbilical cord blood, cytochrome P-450 1A2 activity, and intrauterine growth restriction Am J Epidemiol 163 2006 1035 1041
41. N. Ambalavanan, W.A. Carlo, C.T. D'Angio, S.A. McDonald, A. Das, and D. Schendel Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Cytokines associated with bronchopulmonary dysplasia or death in extremely low birth weight infants Pediatrics 123 2009 1132 1141
42. G.V. Shmarina, A.L. Pukhalsky, S.N. Kokarovtseva, D.A. Pukhalskaya, L.A. Shabalova, and N.I. Kapranov Tumor necrosis factor-alpha/interleukin-10 balance in normal and cystic fibrosis children Mediators Inflamm 10 2001 191 197
43. R.W. Butcher, and E.W. Sutherland Adenosine 3',5'-phosphate in biological materials. I. Purification and properties of cyclic 3',5'-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3',5'-phosphate in human urine J Biol Chem 237 1962 1244 1250
44. M. Chasin, and D.N. Harris Inhibitory and activators of cyclic nucleotide phosphodiesterase Adv Cyclic Nucleotide Res 7 1976 225 264
45. D. Shi, W.L. Padgett, and J.W. Daly Caffeine analogs: effects on ryanodine-sensitive calcium-release channels and GABAA receptors Cell Mol Neurobiol 23 2003 331 347
46. J.W. Daly Caffeine analogs: biomedical impact Cell Mol Life Sci 64 2007 2153 2169
47. I.B. Copland, and M. Post Understanding the mechanisms of infant respiratory distress and chronic lung disease Am J Respir Cell Mol Biol 26 2002 261 265
48. J.J. De Dooy, L.M. Mahieu, and H.P. Van Bever The role of inflammation in the development of chronic lung disease in neonates Eur J Pediatr 160 2001 457 463
49. R.J. Bolt, M.M. van Weissenbruch, H.N. Lafeber, and H.A. Delemarre-van de Waal Glucocorticoids and lung development in the fetus and preterm infant Pediatr Pulmonol 32 2001 76 91
50. S. Kotecha, M. Silverman, R.J. Shaw, and N. Klein Soluble L-selectin concentration in bronchoalveolar lavage fluid obtained from infants who develop chronic lung disease of prematurity Arch Dis Child Fetal Neonatal Ed 78 1998 F143 F147
51. S. Kotecha, L. Wilson, A. Wangoo, M. Silverman, and R.J. Shaw Increase in interleukin (IL)-1 beta and IL-6 in bronchoalveolar lavage fluid obtained from infants with chronic lung disease of prematurity Pediatr Res 40 1996 250 256 (Pubitemid 26249677)
52. C. Schultz, C. Rott, P. Temming, P. Schlenke, J.C. Moller, and P. Bucsky Enhanced interleukin-6 and interleukin-8 synthesis in term and preterm infants Pediatr Res 51 2002 317 322
53. J. Oei, K. Lui, H. Wang, and R. Henry Decreased interleukin-10 in tracheal aspirates from preterm infants developing chronic lung disease Acta Paediatr 91 2002 1194 1199
54. C.A. Jones, R.G. Cayabyab, K.Y. Kwong, C. Stotts, B. Wong, and H. Hamdan Undetectable interleukin (IL)-10 and persistent IL-8 expression early in hyaline membrane disease: a possible developmental basis for the predisposition to chronic lung inflammation in preterm newborns Pediatr Res 39 1996 966 975